Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | ENPP2 | Q13822 | 7/20 | 0.59 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GRK2 | P25098 | 1/20 | 0.46 |
| ▸ | PLEC | Q15149 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.42 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6846208 | 0.91 | USP2 (0.74) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL29358440 | 0.91 | USP2 (0.74) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL12573539 | 0.87 | ENPP2 (0.75) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL29723425 | 0.87 | ENPP2 (0.75) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL29702517 | 0.85 | PHLPP2 (0.61) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL14405194 | 0.85 | ENPP2 (0.66) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL28747691 | 0.84 | ENPP2 (0.51) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL31059047 | 0.84 | ENPP2 (0.51) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL29354476 | 0.84 | USP2 (0.66) | USP2PTPN1ATML3MBTL1ENPP2 | |
| SCHEMBL186094 | 0.84 | USP2 (0.66) | USP2PTPN1ATML3MBTL1ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570859-B2 | Primer, printing set, printing method, and printing apparatus | RICOH COMPANY, LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-12552745-B2 | Compound for optical materials, curable composition, cured body, and optical article | TOKUYAMA CORPORATION (JP) | 2026-02-17 | — | — | US | disclosed |
| EP-4692863-A1 | METHOD FOR PRODUCING LENS | Sumitomo Bakelite Co.Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20250355282-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12459276-B2 | Contact member, drying apparatus, and printing apparatus for treating liquid-coated substrates | RICOH COMPANY, LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| US-12441902-B2 | Ink set, image forming method, and image forming apparatus | RICOH COMPANY, LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-20250257162-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| US-20250242599-A1 | LIQUID EJECTION APPARATUS | RICOH COMPANY, LTD. (JP) | 2025-07-31 | — | — | US | disclosed |
| US-12359081-B2 | Ink, method for producing ink, and inkjet system | RICOH COMPANY, LTD. (JP) | 2025-07-15 | — | — | US | disclosed |
| EP-4560367-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-05-28 | — | — | EP | disclosed |
| CN-116669754-A | Fibrin hydrogel | 梅约医学教育与研究基金会 | 2023-08-29 | — | — | CN | disclosed |
| CN-116034318-A | Colored photosensitive resin composition, cured product, display device, and method for producing cured product | 东丽株式会社 | 2023-04-28 | — | — | CN | disclosed |
| EP-3521875-B1 | POLARIZING LAMINATE AND EYE GLASSES | SUMITOMO BAKELITE CO (JP) | 2023-04-19 | — | — | EP | disclosed |
| EP-4163270-A1 | COMPOUND FOR OPTICAL MATERIAL, CURABLE COMPOSITION, CURED BODY, AND OPTICAL ARTICLE | Tokuyama Corporation (JP) | 2023-04-12 | — | — | EP | disclosed |
| WO-2022104128-A9 | FIBRIN HYDROGELS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2023-03-30 | — | — | WO | disclosed |
| CN-115768746-A | Compound for optical material, curable composition, cured product, and optical article | 株式会社德山 | 2023-03-07 | — | — | CN | disclosed |
| WO-2022224915-A1 | CONTACT MEMBER, DRYING APPARATUS, AND PRINTING APPARATUS | RICOH COMPANY, LTD. (JP) | 2022-10-27 | — | — | WO | disclosed |
| CN-111727402-B | Functional laminate and functional lens using same | 株式会社德山 | 2022-07-15 | — | — | CN | disclosed |
| US-20220169877-A1 | INK, METHOD FOR PRODUCING INK, AND INKJET SYSTEM | RICOH COMPANY, LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| WO-2022104128-A1 | FIBRIN HYDROGELS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2022-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552745-B2 | Compound for optical materials, curable composition, cured body, and optical article | C5, SCO2, ZYX | THRB 2158/4885USP2 830/4885PTPN1 3567/4885 |
| US-12570859-B2 | Primer, printing set, printing method, and printing apparatus | MED1, SETDB1, MED25 | THRB 4470/4885USP2 3867/4885PTPN1 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.